Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-14-067233
Filing Date
2014-11-12
Accepted
2014-11-12 16:49:48
Documents
1
Period of Report
2014-11-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 v393016_form3.html 3  
1 FORM 3 v393016_form3.xml 3 2541
  Complete submission text file 0001144204-14-067233.txt   3927
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Issuer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 630 FIFTH AVENUE, 22ND FLOOR NEW YORK NY 10111
Business Address
Akers Joseph A (Reporting) CIK: 0001379888 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-27436 | Film No.: 141214734